2011 J.P. Morgan Healthcare Conference
Orexigen Nears PDUFA as Vivus, Arena Keep Trying
By Tom Wall
Friday, January 14, 2011
SAN FRANCISCO If there was a trifecta for biotechs developing new weight-loss therapies, presentations by Vivus Inc., Orexigen Therapeutics Inc. and Arena Pharmaceuticals Inc. Wednesday at the J.P. Morgan Healthcare conference would have given you a pretty good idea of who to pick for win, place and show.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.